China Blood Pressure Monitoring Devices Market Size, Share - Growth Analysis Report and Forecast Trends 2026-2030

China is one of the world's largest single-country markets for blood pressure monitoring devices, supported by more than 300 million hypertension patients and a growing population of elderly users who require routine measurement. The market is shifting from manual aneroid devices toward digital upper-arm and wrist monitors, with home-use devices now accounting for a meaningful share of total volume. Distribution is increasingly omnichannel, spanning hospitals, pharmacies, e-commerce platforms such as JD.com and Tmall, and community health centers.

• •Market size in 2025 is approximately USD 4.34 billion, growing at roughly 8.54% CAGR.
• •Digital blood pressure monitors are overtaking aneroid devices as the dominant product category in volume terms.
• •Home-use and connected monitoring devices represent the fastest-expanding sub-segment.

Hypertension prevalence in China has been climbing steadily, with national health surveys indicating that roughly one in three adults is affected, and cardiovascular disease remains the leading cause of mortality in the country. Government programs under Healthy China 2030 emphasize chronic disease prevention, early screening, and primary-care-based management of hypertension, all of which depend on reliable monitoring devices. At the same time, rising disposable incomes, greater health awareness after the COVID-19 pandemic, and a growing elderly population are accelerating household adoption of digital monitors.

• •Aging demographics: more than 260 million Chinese are aged 60 and above, lifting demand for routine BP monitoring.
• •National policies promote chronic disease management at the community and household level.
• •Consumer preference is shifting toward smart, Bluetooth- and Wi-Fi-enabled monitors with mobile app integration.

By product, the market divides into aneroid BP monitors, digital blood pressure monitors (including upper-arm and wrist types), ambulatory BP monitors, and hospital-grade multi-parameter monitors. By end-use, the segments are hospitals, ambulatory surgery centers, clinics, and homecare, with homecare expanding most rapidly. Regionally, demand is strongest in the Yangtze River Delta, the Pearl River Delta, and the Beijing-Tianjin-Hebei region, where healthcare spending, e-commerce penetration, and the density of tertiary hospitals are highest.

• •Digital upper-arm monitors are the largest product category; wrist and ambulatory devices are growing fastest.
• •Homecare is the fastest-growing end-use segment, while hospitals remain the largest single revenue contributor.
• •Tier-1 and Tier-2 cities account for a disproportionate share of premium connected device sales.

What are the recent trends and outlook?

Three structural trends are shaping the next phase of the market: integration with telehealth platforms, miniaturization and wearable form factors, and stricter regulatory oversight of accuracy claims. The National Medical Products Administration (NMPA) has tightened standards for clinical validation of consumer BP monitors, raising the bar for compliant products. Over the forecast horizon, recurring-revenue models such as subscription-based remote monitoring services are expected to complement one-time device sales, supporting sustained double-digit growth in value terms in the homecare segment.

• •Connected and app-enabled devices are forecast to grow above the market average through 2030.
• •Regulatory tightening on measurement accuracy is consolidating the market around compliant, clinically validated brands.
• •Telehealth integration and chronic disease management partnerships are emerging as key differentiators.